HIT vs TECH
Health In Tech, Inc. Class A Common Stock (HIT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Health In Tech, Inc. Class A Common Stock (HIT) is a software - application company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported HIT revenue for 2024-12-31 was $19.5M. Net income was $670.5K. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. HIT currently screens at market cap $63.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
HIT currently screens at market cap $63.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the HIT and TECH stock pages for the full models.
Not investment advice.